Apogee Therapeutics, Inc.
USD78.71
-0.59 (-0.74%)
CEO
Michael Thomas Henderson
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$78.15
Prev. Close
$79.30
Day Low
$78.05
Day High
$80.22
52W Low
$34.34
52W High
$95.31
Market Cap
$4.87B
Volume
1.10M
| 1,341 |
| $82.58 |
| 8 May 2026 | Dambkowski Carl | Chief Medical Officer | M-Exempt | Acquired | 4,125 | $22.86 |
| 8 May 2026 | Dambkowski Carl | Chief Medical Officer | S-Sale | Disposed | 3,700 | $83.92 |
| 8 May 2026 | Dambkowski Carl | Chief Medical Officer | S-Sale | Disposed | 1,800 | $84.60 |
| 8 May 2026 | Dambkowski Carl | Chief Medical Officer | M-Exempt | Disposed | 4,125 | $22.86 |
| 4 May 2026 | Henderson Jane | Chief Financial Officer | S-Sale | Disposed | 811 | $81.02 |
| 4 May 2026 | Henderson Jane | Chief Financial Officer | S-Sale | Disposed | 900 | $82.60 |
| 4 May 2026 | Henderson Jane | Chief Financial Officer | S-Sale | Disposed | 289 | $83.16 |
| 20 Apr 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | M-Exempt | Acquired | 3,000 | $22.86 |